(R)-3-(Boc-Amino)piperidine CAS 309956-78-3 Linagliptin and Alogliptin Benzoate Intermediate Purity ≥99.0% Factory

Short Description:

Chemical Name: (R)-3-(Boc-Amino)piperidine

CAS: 309956-78-3

Chiral Purity: ≥99.0%

Chemical Purity (GC): ≥99.0%

Appearance: White Powder

Intermediate for Linagliptin (CAS: 668270-12-0) and Alogliptin Benzoate (CAS: 850649-62-6)

High Quality, Commercial Production

E-Mail: alvin@ruifuchem.com

Send email to us

Product Detail

Product Tags

Description:

Manufacturer Supply Linagliptin and Related Intermediates:
Linagliptin CAS 668270-12-0
Linagliptin Parent Nucleus Intermediate CAS 853029-57-9
8-Bromo-3-Methylxanthine CAS 93703-24-3
8-Bromo-7-(2-butyn-1-yl)-3-methylxanthine CAS 666816-98-4
2-(Chloromethyl)-4-Methylquinazoline CAS 109113-72-6
(R)-3-(Boc-Amino)piperidine CAS 309956-78-3
(R)-(-)-3-Aminopiperidine Dihydrochloride CAS 334618-23-4
1-Bromo-2-Butyne CAS 3355-28-0

Chemical Properties:

Chemical Name	(R)-3-(Boc-Amino)piperidine
Synonyms	(R)-3-(tert-Butoxycarbonylamino)piperidine
CAS Number	309956-78-3
CAT Number	RF-PI499
Stock Status	In Stock, Production Scale Up to Tons
Molecular Formula	C10H20N2O2
Molecular Weight	200.28
Solubility	Soluble in Methanol and Ethanol
Brand	Ruifu Chemical

Specifications:

Item	Specifications
Appearance	White Powder
Melting Point	120.0~125.0℃
Water (K.F)	≤0.50%
Residue on Ignition	≤0.50%
Chiral Purity	≥99.0%
Chemical Purity (GC)	≥99.0%
Total Impurities	≤1.0%
Test Standard	Enterprise Standard
Usage	Intermediate of Linagliptin (CAS: 668270-12-0), Alogliptin Benzoate (CAS: 850649-62-6)

Package & Storage:

Package: Bottle, Aluminium foil bag, 25kg/Cardboard Drum, or according to customer's requirement.

Storage Condition: Store in sealed containers at cool and dry place; Protect from light and moisture.

Advantages:

FAQ:

Application:

(R)-3-(Boc-Amino)piperidine (CAS: 309956-78-3) has been used as a reactant for the preparation of dipeptidyl peptidase IV inhibitors derived from Alogliptin Benzoate (CAS: 850649-62-6). (R)-3-(Boc-Amino)piperidine also can be used as an intermediate of Linagliptin (CAS: 668270-12-0). Linagliptin is a novel potent and selective dipeptidyl peptidase-4 (DPP-4) inhibitor with potential use in the treatment of type 2 diabetes, was approved by the US FDA on 2 May 2011.